Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

Treusch, Sebastian, Hamamichi, Shusei, Goodman, Jessica L., Matlack, Kent E. S., Chung, Chee Yeun, Baru, Valeriya, Shulman, Joshua M., Parrado, Antonio, Bevis, Brooke J., Valastyan, Julie S., Han, Haesun, Lindhagen-Persson, Malin, Reiman, Eric M., Evans, Denis A., Bennett, David A., Olofsson, Anders, DeJager, Philip L., Tanzi, Rudolph E., Caldwell, Kim A., Caldwell, Guy A., Lindquist, Susan·2011·Science
DOI 10.1126/science.1213210

Cited by (381)

Items 101–200 of 381

  1. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease
    David Alan Bennett, Lei Yu, Philip L. De Jager · 2014 · Biochemical Pharmacology
  2. Contribution of Yeast Models to Neurodegeneration Research
    Clara Pereira, Cláudia Bessa, Joana Soares, Mariana Leão, Lucı́lia Saraiva · 2012 · BioMed Research International
  3. Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect
    Guido Veit, Kathryn E. Oliver, Pirjo M. Apaja, Doranda Perdomo, Aurélien Bidaud-Meynard, Sheng-Ting Lin, Jingyu Guo, Mert Icyuz, Eric J. Sorscher, John L. Hartman et al. · 2016 · PLoS Biology
  4. Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model
    Liao, Fan, Jiang, Hong, Srivatsan, Subhashini, Xiao, Qingli, Lefton, Katheryn B, Yamada, Kaoru, Mahan, Thomas E, Lee, Jin-Moo, Shaw, Andrey S, Holtzman, David M · 2015 · Molecular Neurodegeneration
  5. Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast
    Xin Chen, Dina Petranović · 2015 · FEMS Yeast Research
  6. Flavonoid‐Derived Human Phenyl‐γ‐Valerolactone Metabolites Selectively Detoxify Amyloid‐β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease
    Roberta Ruotolo, Ilaria Minato, Pietro La Vitola, Luisa Artioli, Claudio Curti, Valentina Franceschi, Nicoletta Brindani, Davide Amidani, Laura Colombo, Mario Salmona et al. · 2020 · Molecular Nutrition & Food Research
  7. Novel amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity
    Christian Gallrein, Manuel Iburg, Tim Michelberger, Alen Koçak, Dmytro Puchkov, Fan Liu, Sara Ayala, Tanmoyita Nayak, Gabriele S. Kaminski Schierle, Janine Kirstein · 2020 · Progress in Neurobiology
  8. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway
    Kotaro Furusawa, Toshiyuki Takasugi, Yung‐Wen Chiu, Yukiko Hori, Taisuke Tomita, Mitsunori Fukuda, Shin‐ichi Hisanaga · 2019 · Journal of Biological Chemistry
  9. Biopharmaceutical protein production by Saccharomyces cerevisiae : current state and future prospects
    Mingtao Huang, Jichen Bao, Jens Nielsen · 2014 · Pharmaceutical Bioprocessing
  10. Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy
    Sigal Rencus‐Lazar, Yasmin DeRowe, Hanaa Adsi, Ehud Gazit, Dana Laor Bar‐Yosef · 2019 · Frontiers in Molecular Biosciences
  11. Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
    Adam D. Kline · 2012 · Alzheimer s Research & Therapy
  12. IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking
    Anthony J. Carlos, Liqi Tong, G. Aleph Prieto, Carl W. Cotman · 2017 · Journal of Neuroinflammation
  13. Caenorhabditis elegans : What We Can and Cannot Learn from Aging Worms
    Jan Gruber, Ce-Belle Chen, Sheng Fong, Li Fang Ng, Emelyne Teo, Barry B. Halliwell · 2014 · Antioxidants and Redox Signaling
  14. Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors, antioxidants, and neuroprotective agents
    Chuan‐Jun Lu, Yueyan Guo, Jianheng Li, Meicun Yao, Qiongfeng Liao, Zhi Xie, Xingshu Li · 2012 · Bioorganic & Medicinal Chemistry Letters
  15. Alzheimer's disease genes and autophagy
    Yoon, Seung-Yong, Kim, Dong-Hou · 2016 · Brain Research
  16. Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced Proteotoxicity
    Can Kayatekin, Audra L. Amasino, Giorgio Gaglia, Jason A. Flannick, Julia Maeve Bonner, Saranna Fanning, Priyanka S. Narayan, M. Inmaculada Barrasa, David Pincus, Dirk Landgraf et al. · 2018 · Cell
  17. Exploring the power of yeast to model aging and age-related neurodegenerative disorders
    Ana Vanessa Oliveira, Rita Vilaça, Cláudia Nunes dos Santos, Vítor Costa, Regina Menezes · 2016 · Biogerontology
  18. A Generic Method for Design of Oligomer-Specific Antibodies
    Kristoffer Brännström, Malin Lindhagen‐Persson, Anna L. Gharibyan, Irina Iakovleva, Monika Vestling, Mikael E. Sellin, Thomas Brännström, Ludmilla A. Morozova‐Roche, Lars Forsgren, Anders Olofsson · 2014 · PLoS ONE
  19. Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
    Qiying Sun, Nina Xie, Beisha Tang, Rena Li, Yong Shen · 2017 · Frontiers in Molecular Neuroscience
  20. Blood–brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals
    Ida Juul Rasmussen, Anne Tybjærg‐Hansen, Katrine Laura Rasmussen, Børge Grønne Nordestgaard, Ruth Frikke‐Schmidt · 2019 · European Journal of Epidemiology
  21. Metabolite assemblies: A surprising extension to the amyloid hypothesis
    Nidhi Gour, Ehud Gazit · 2021 · Current Opinion in Chemical Biology
  22. Alzheimer’s as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks
    Castrillo, Juan I., Oliver, Stephen G. · 2016 · Methods in Molecular Biology
  23. Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations
    Azarnia Tehran, Domenico, López-Hernández, Tania, Maritzen, Tanja · 2019 · Cells
  24. Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites
    Marine Bretou, Ragna Sannerud, Abril Escamilla‐Ayala, Tom Leroy, Céline Vrancx, Zoë P. Van Acker, Anika Perdok, Wendy Vermeire, Inge Vorsters, Sophie Van Keymolen et al. · 2024 · Developmental Cell
  25. The Sybtraps: Control of Synaptobrevin Traffic by Synaptophysin, α‐Synuclein and AP‐180
    Sarah L. Gordon, Michael Alan Cousin · 2013 · Traffic
  26. Phosphatidylinositol 4-Kinases and PI4P Metabolism in the Nervous System: Roles in Psychiatric and Neurological Diseases
    Emma L. Clayton, Shane Minogue, Mark G. Waugh · 2012 · Molecular Neurobiology
  27. Turning CALM into excitement: AP180 and CALM in endocytosis and disease
    Tanja Maritzen, Seong Joo Koo, Volker Haucke · 2012 · Biology of the Cell
  28. State of Play in Alzheimer’s Disease Genetics
    Jin-Bao Zhu, Chen‐Chen Tan, Lan Tan, Jin‐Tai Yu · 2017 · Journal of Alzheimer s Disease
  29. ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans
    Edward F. Griffin, Samuel E. Scopel, Cayman A. Stephen, Adam C. Holzhauer, Madeline A Vaji, Ryan A. Tuckey, Laura A. Berkowitz, Kim A. Caldwell, Guy A. Caldwell · 2019 · Disease Models & Mechanisms
  30. Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease
    Laura E. Donovan, Eric B. Dammer, Duc Minh Duong, John Hanfelt, Allan I. Levey, Nicholas T. Seyfried, James J. Lah · 2013 · Alzheimer s Research & Therapy
  31. Mitochondrion-mediated cell death: dissecting yeast apoptosis for a better understanding of neurodegeneration
    Ralf J. Braun · 2012 · Frontiers in Oncology
  32. Oxidative Stress and Amyloid Toxicity: Insights From Yeast
    Mauro Braga França, K. Lima, Elis C. A. Eleuthério · 2016 · Journal of Cellular Biochemistry
  33. Protein aggregation into insoluble deposits protects from oxidative stress
    Anita Čarija, Susanna Navarro, Natalia Sánchez de Groot, Salvador Ventura · 2017 · Redox Biology
  34. In vivo induction of membrane damage by β-amyloid peptide oligomers
    Carl Julien, Colson Tomberlin, Christine M. Roberts, Aumbreen Akram, Gretchen H. Stein, Michael A. Silverman, Christopher D. Link · 2018 · Acta Neuropathologica Communications
  35. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma
    Jeremy J. Ryan, Macy L. Sprunger, Kayla Holthaus, James Shorter, Meredith E. Jackrel · 2019 · Journal of Biological Chemistry
  36. Mammalian amyloidogenic proteins promote prion nucleation in yeast
    Pavithra Chandramowlishwaran, Meng Sun, Kristin L. Casey, Andrey V. Romanyuk, Anastasia V. Grizel, Julia V. Sopova, Aleksandr A. Rubel, Carmen I. Nussbaum-Krammer, Ina Maja Vorberg, Yury O. Chernoff · 2018 · Journal of Biological Chemistry
  37. Redox modulation of stress resilience by Crocus sativus L. for potential neuroprotective and anti-neuroinflammatory applications in brain disorders: From molecular basis to therapy
    Maria Concetta Scuto, Sergio Modafferi, Francesco Rampulla, Vincenzo Zimbone, Mario Tomasello, Sestina Maria Spanò, Maria Laura Ontario, Agostino Palmeri, Angela Trovato Salinaro, Rosalba Siracusa et al. · 2022 · Mechanisms of Ageing and Development
  38. Recent Insights on Alzheimer’s Disease Originating from Yeast Models
    David Seynnaeve, Mara Del Vecchio, Gernot Fruhmann, Joke Verelst, Melody Cools, Jimmy Beckers, Daniel P. Mulvihill, Joris Winderickx, Vanessa Franssens · 2018 · International Journal of Molecular Sciences
  39. Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning
    Vanessa E. Gray, Katherine A. Sitko, Floriane Z. Ngako Kameni, Miriam Williamson, Jason J. Stephany, Nicholas Hasle, Douglas M. Fowler · 2019 · G3 Genes Genomes Genetics
  40. Sorting Out Sorting Nexins Functions in the Nervous System in Health and Disease
    Neide Vieira, Teresa Rito, Margarida Correia‐Neves, Nuno Sousa · 2021 · Molecular Neurobiology
  41. Curcumin Prevents Formation of Polyglutamine Aggregates by Inhibiting Vps36, a Component of the ESCRT-II Complex
    Meenakshi Verma, Abhishek A. Sharma, Swarna Naidu, Ankan Kumar Bhadra, Ritushree Kukreti, Vibha Taneja · 2012 · PLoS ONE
  42. Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
    Sofia Essayan-Perez, Bo Zhou, Amber M. Nabet, Marius Wernig, Yu‐Wen Alvin Huang · 2019 · Neurobiology of Disease
  43. Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes
    Olga Sin, Ellen A. A. Nollen · 2015 · Cellular and Molecular Life Sciences
  44. Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins
    Sei-Kyoung Park, Fatih Arslan, Vydehi Kanneganti, Sami J. Barmada, Pravinkumar Purushothaman, Subhash Chandra Verma, Susan Weiss Liebman · 2018 · Prion
  45. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
    Jiyeon Lee, Haeryung Lee, Hyein G. Lee, Miram Shin, Min-Gi Shin, Jinsoo Seo, Eun Jeong Lee, Sun Ah Park, Soochul Park · 2023 · Nature Communications
  46. β2-Microglobulin Amyloid Fibrils Are Nanoparticles That Disrupt Lysosomal Membrane Protein Trafficking and Inhibit Protein Degradation by Lysosomes
    Toral Jakhria, Andrew L. Hellewell, M. Porter, M. P. Jackson, Kevin W. Tipping, Wei-Feng Xue, S. Radford, E. Hewitt · 2014 · Journal of Biological Chemistry
  47. The effect of ethyl acetate extract from persimmon leaves on Alzheimer's disease and its underlying mechanism
    Shun-Wang Huang, Wei Wang, Mengyu Zhang, Qing-Bo Liu, Shengyong Luo, Ying Peng, Bei Sun, Deling Wu, Shao‐Jiang Song · 2016 · Phytomedicine
  48. Yeast buddies helping to unravel the complexity of neurodegenerative disorders
    Gernot Fruhmann, David Seynnaeve, Ju Zheng, Karen Ven, Sofie Molenberghs, Tobias Wilms, Beidong Liu, Joris Winderickx, Vanessa Franssens · 2016 · Mechanisms of Ageing and Development
  49. Interaction of Aβ 1–42 peptide or their variant with model membrane of different composition probed by infrared nanospectroscopy
    Sarah Henry, Nicolas Bercu, Claude Bobo, Christophe Cullin, Michaël Molinari, Sophie Lecomte · 2017 · Nanoscale
  50. Studying Spatial Protein Quality Control, Proteopathies, and Aging Using Different Model Misfolding Proteins in S. cerevisiae
    Kara L. Schneider, Thomas Nyström, Per O. Widlund · 2018 · Frontiers in Molecular Neuroscience
  51. A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans
    Bryan Martinez, Hanna Kim, Arpita Ray, Guy A. Caldwell, Kim A. Caldwell · 2015 · Cell Death and Disease
  52. Histone deacetylase–mediated regulation of endolysosomal pH
    Hari Prasad, Rajini Rao · 2018 · Journal of Biological Chemistry
  53. Neutral Charged Immunosensor Platform for Protein-based Biomarker Analysis with Enhanced Sensitivity
    Yifan Dai, Liang‐Yuan Chiu, Yinuo Chen, Shiyi Qin, Xiaowei Wu, Chung-Chiun Liu · 2018 · ACS Sensors
  54. Impacts of PICALM and CLU variants associated with Alzheimer’s disease on the functional connectivity of the hippocampus in healthy young adults
    Peng Zhang, Wen Qin, Dawei Wang, Bing Liu, Yunting Zhang, Tianzi Jiang, Chunshui Yu · 2014 · Brain Structure and Function
  55. High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model
    Mondal, Sudip, Hegarty, Evan, Sahn, James J., Scott, Luisa L., Gökçe, Sertan Kutal, Martin, Chris, Ghorashian, Navid, Satarasinghe, Praveen Navoda, Iyer, Sangeetha, Sae-Lee, Wisath et al. · 2018 · ACS Chemical Neuroscience
  56. Role of Presenilin in Mitochondrial Oxidative Stress and Neurodegeneration in Caenorhabditis elegans
    Shaarika Sarasija, Kenneth R. Norman · 2018 · Antioxidants
  57. Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms
    Xi Chen, Robert D. Burgoyne · 2012 · BMC Genomics
  58. Genome-wide analysis ofSaccharomyces cerevisiaeidentifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis
    S. Nair, Mathew D. Traini, Ian W. Dawes, G. G. Perrone · 2014 · Molecular Biology of the Cell
  59. Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration
    Edward F. Griffin, Xiaohui Yan, Kim A. Caldwell, Guy A. Caldwell · 2018 · Human Molecular Genetics
  60. RETRACTED: Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease
    Panchanan Maiti, Jayeeta Manna, Zoe N. Burch, Denise B. Flaherty, Joseph Larkin, Gary Leo Dunbar · 2020 · International Journal of Molecular Sciences · Retracted
  61. Tumor suppressor protein p53 expressed in yeast can remain diffuse, form a prion, or form unstable liquid-like droplets
    Sei-Kyoung Park, Sangeun Park, Christine Pentek, Susan Weiss Liebman · 2020 · iScience
  62. Invertebrate Models of Alzheimer's Disease
    Siddhita D. Mhatre, Brie E. Paddock, Aleister J. Saunders, Daniel R. Marenda · 2012 · Journal of Alzheimer s Disease
  63. RETRACTED: An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients
    Ebbe Toftgaard Poulsen, Filomena Iannuzzi, Helle Foverskov Rasmussen, Thorsten J. Maier, Jan J. Enghild, Arne Lund Jørgensen, Carmela Matrone · 2017 · Frontiers in Molecular Neuroscience · Retracted
  64. Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast
    Xin Chen, Markus M.M. Bisschops, Nisha Rani Agarwal, Boyang Ji, Kumaravel Ponnandai Shanmugavel, Dina Petranović · 2017 · Frontiers in Molecular Neuroscience
  65. Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery
    Tatiana Alexandrovna Chernova, Yury O. Chernoff, Keith D. Wilkinson · 2019 · Molecules
  66. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier
    Kassandra Kisler, Abhay P. Sagare, Divna Lazić, Sam A. Bazzi, Erica J. Lawson, Ching-Ju Hsu, Yaoming Wang, Anita Ramanathan, Amy R. Nelson, Zhen Zhao et al. · 2023 · Molecular Neurodegeneration
  67. Drosophila Small Heat Shock Proteins: An Update on Their Features and Functions
    Geneviève Morrow, Robert M. Tanguay · 2015 · Heat shock proteins
  68. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology
    Macy L. Sprunger, Ken Lee, Brian S. Sohn, Meredith E. Jackrel · 2022 · iScience
  69. The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
    Julia Ring, Jelena Tadić, Selena Ristic, Michael Poglitsch, Martina Bergmann, Nemanja Radic, Dirk Mossmann, YongTian Liang, Marta Maglione, Andrea Jerkovic et al. · 2022 · EMBO Molecular Medicine
  70. Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease.
    Samantha L. Rosenthal, Xingbin Wang, F. Yesim Demirci, M. Michael Barmada, Mary Ganguli, Oscar L. López, M. Ilyas Kamboh · 2012 · Europe PMC (PubMed Central)
  71. Yeast genetic screen reveals novel therapeutic strategy for ALS
    Matthew D. Figley, Aaron D. Gitler · 2013 · Rare Diseases
  72. New Therapeutic Strategies for Cancer and Neurodegeneration Emerging from Yeast Cell-based Systems
    Clara Pereira, Mariana Leao, Joana Soares, Cláudia Bessa, Lucı́lia Saraiva · 2012 · Current Pharmaceutical Design
  73. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies
    Michelle Briffa, Stephanie Ghio, Johanna Neuner, Alison J. Gauci, Rebecca Cacciottolo, Christelle Marchal, Mario Caruana, Christophe Cullin, Neville Vassallo, Ruben J. Cauchi · 2016 · Neuroscience Letters
  74. ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency
    Philippe Joly, Hélène Vignaud, Julie S. Di Martino, Mathias Ruiz, Roman Garin, Lioara Restier, Abdelouahed Belmalih, Christelle Marchal, Christophe Cullin, Benoı̂t Arveiler et al. · 2017 · PLoS ONE
  75. Yeast at the Forefront of Research on Ageing and Age-Related Diseases
    Belém Sampaio‐Marques, William C. Burhans, Paula Ludovico · 2019 · Progress in molecular and subcellular biology
  76. Ca2+ enhances Aβ polymerization rate and fibrillar stability in a dynamic manner
    Kristoffer Brännström, Anders Öhman, Malin Lindhagen‐Persson, Anders Olofsson · 2012 · Biochemical Journal
  77. New Insights to Clathrin and Adaptor Protein 2 for the Design and Development of Therapeutic Strategies
    Ebbe Toftgaard Poulsen, Agnete Larsen, Alen Zollo, Arne Jørgensen, Kristian W. Sanggaard, Jan J. Enghild, Carmela Matrone · 2015 · International Journal of Molecular Sciences
  78. Reactive Oxygen Species Modulate Activity-Dependent AMPA Receptor Transport in C. elegans
    Rachel L. Doser, Gregory C. Amberg, Frédéric J. Hoerndli · 2020 · Journal of Neuroscience
  79. Partial loss of CALM function reduces Aβ42 production and amyloid depositionin vivo
    Kunihiko Kanatsu, Yukiko Hori, Sho Takatori, Toshio Watanabe, Takeshi Iwatsubo, Taisuke Tomita · 2016 · Human Molecular Genetics
  80. Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins
    Ralf J. Braun · 2015 · Frontiers in Molecular Neuroscience
  81. The Biochemical Properties and Functions of CALM and AP180 in Clathrin Mediated Endocytosis
    Lia Moshkanbaryans, Ling-Shan Chan, Mark Evan Graham · 2014 · Membranes
  82. Animal Models of Alzheimer’s Disease
    Morgan Newman, Doris Kretzschmar, Imran Khan, Mengqi Chen, Giuseppe Verdile, Michael T. Lardelli · 2017 · Elsevier eBooks
  83. Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases
    Hari Prasad, Rajini Rao · 2020 · Reviews of physiology, biochemistry and pharmacology
  84. An isogenic panel of App knock-in mouse models: Profiling β-secretase inhibition and endosomal abnormalities
    Naoto Watamura, Kaori Sato, Gen Shiihashi, Ayami Iwasaki, Naoko Kamano, Mika Takahashi, Misaki Sekiguchi, Naomi Mihira, Ryo Fujioka, Kenichi Nagata et al. · 2022 · Science Advances
  85. Yeast as a Model for Alzheimer’s Disease: Latest Studies and Advanced Strategies
    Mathias Verduyckt, Hélène Vignaud, Tine Bynens, Jeff Van den Brande, Vanessa Franssens, Christophe Cullin, Joris Winderickx · 2015 · Methods in molecular biology
  86. Microbial Pathogenesis and Pathophysiology of Alzheimer's Disease: A Systematic Assessment of Microorganisms' Implications in the Neurodegenerative Disease
    Temitope Cyrus Ekundayo, Tosin Abiola Olasehinde, Kunle Okaiyeto, Anthony Ifeanyi Okoh · 2021 · Frontiers in Neuroscience
  87. Tau Monoclonal Antibody Generation Based on Humanized Yeast Models
    Joëlle Rosseels, Jeff Van den Brande, Marie Violet, Dirk Jacobs, Pierre Grognet, Juan M. Lopez, Isabelle Huvent, Marina Caldara, Erwin Swinnen, Anthony Papegaey et al. · 2014 · Journal of Biological Chemistry
  88. ALS Yeast Models—Past Success Stories and New Opportunities
    Sonja E. Di Gregorio, Martin L. Duennwald · 2018 · Frontiers in Molecular Neuroscience
  89. Cell type-specific functions of Alzheimer's disease endocytic risk genes
    Maninger, Johanna-Katharina, Nowak, Karolina, Goberdhan, Srilakshmi, O'Donoghue, Rachel, Connor-Robson, Natalie · 2024 · Philosophical Transactions of the Royal Society B: Biological Sciences
  90. Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer
    Yun Wei, Xinlei Du, Hongling Guo, Jingjing Han, Meixia Liu · 2024 · Frontiers in Aging Neuroscience
  91. Application of Yeast to Study the Tau and Amyloid-β Abnormalities of Alzheimer's Disease
    Afsaneh Porzoor, Ian George Macreadie · 2013 · Journal of Alzheimer s Disease
  92. Analysis of ER Resident Proteins in Saccharomyces cerevisiae: Implementation of H/ KDEL Retrieval Sequences
    Carissa L. Young, David L. Raden, Anne Skaja Robinson · 2013 · Traffic
  93. Methylation Profiling RIN3 and MEF2C Identifies Epigenetic Marks Associated with Sporadic Early Onset Alzheimer’s Disease
    Kirsty A. Boden, Imelda Barber, Naomi S. Clement, Tulsi Patel, Tamar Guetta‐Baranes, Keeley J. Brookes, Sally Chappell, Jim Craigon, Natalie H. Chapman, Kevin Morgan et al. · 2017 · Journal of Alzheimer s Disease Reports
  94. How Surrogate and Chemical Genetics in Model Organisms Can Suggest Therapies for Human Genetic Diseases
    Katherine A Strynatka, Michelle C Gurrola-Gal, Jason N. Berman, Christopher R. McMaster · 2018 · Genetics
  95. Yeast as a model to study protein misfolding in aged cells
    Sonja E. Di Gregorio, Martin L. Duennwald · 2018 · FEMS Yeast Research
  96. Research progress on phosphatidylinositol 4-kinase inhibitors
    Gang Li, Yanting Wu, Yali Zhang, Huamin Wang, Mengjie Li, Dengqin He, Wen xian Guan, Hongliang Yao · 2023 · Biochemical Pharmacology
  97. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer’s disease
    Rasoul Godini, Roger Pocock, Hossein Fallahi · 2019 · PLoS ONE
  98. Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
    Pratip Rana, Edian F. Franco, Yug Rao, Khajamoinuddin Syed, Debmalya Barh, Vasco Azevedo, Rommel Thiago Jucá Ramos, Preetam Ghosh · 2019 · International Journal of Molecular Sciences
  99. The blood–brain barrier as a treatment target for neurodegenerative disorders
    Ruslan Rust, Abhay P. Sagare, Mingzi Zhang, Berislav V. Zloković, Kassandra Kisler · 2025 · Expert Opinion on Drug Delivery
  100. Mice deficient for wild-type p53-induced phosphatase 1 display elevated anxiety- and depression-like behaviors
    C.S. Ruan, Fiona H. Zhou, Z.Y. He, SH Wang, Chunzheng Yang, Yun Shen, Ying Guo, Hui Zhao, L. Chen, Dawei Liu et al. · 2015 · Neuroscience